FMTX Forma Therapeutics Holdings Inc

Price (delayed)

$25.99

Market cap

$1.23B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.49

Enterprise value

$1.14B

Highlights
FMTX's quick ratio has soared by 196% year-on-year but it is down by 3.4% since the previous quarter
Forma Therapeutics Holdings's EPS has plunged by 102% from the previous quarter
Forma Therapeutics Holdings's revenue has plunged by 100% YoY

Key stats

What are the main financial stats of FMTX
Market
Shares outstanding
47.37M
Market cap
$1.23B
Enterprise value
$1.14B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$127.83M
EBITDA
-$126.54M
Free cash flow
-$103.44M
Per share
EPS
-$6.49
Free cash flow per share
-$2.19
Book value per share
$13.01
Revenue per share
$0
TBVPS
$13.75
Balance sheet
Total assets
$650.24M
Total liabilities
$33.77M
Debt
$8.26M
Equity
$616.47M
Working capital
$545.31M
Liquidity
Debt to equity
0.01
Current ratio
20.1
Quick ratio
19.29
Net debt/EBITDA
0.71
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-21.6%
Return on equity
-22.9%
Return on invested capital
-39.2%
Return on capital employed
-20.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FMTX stock price

How has the Forma Therapeutics Holdings stock price performed over time
Intraday
2.52%
1 week
13.69%
1 month
-4.2%
1 year
N/A
YTD
-25.53%
QTD
-7.24%

Financial performance

How have Forma Therapeutics Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$128.2M
Net income
-$117.6M
Gross margin
N/A
Net margin
N/A
Forma Therapeutics Holdings's revenue has plunged by 100% YoY
FMTX's gross profit has dropped by 100% year-on-year
FMTX's net income has dropped by 99% year-on-year and by 67% since the previous quarter
Forma Therapeutics Holdings's operating income has decreased by 20% YoY and by 3.2% QoQ

Growth

What is Forma Therapeutics Holdings's growth rate over time

Valuation

What is Forma Therapeutics Holdings stock price valuation
P/E
N/A
P/B
2
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Forma Therapeutics Holdings's EPS has plunged by 102% from the previous quarter
The stock's price to book (P/B) is 39% less than its last 4 quarters average of 3.3
FMTX's equity is down by 4.9% QoQ
Forma Therapeutics Holdings's revenue has plunged by 100% YoY

Efficiency

How efficient is Forma Therapeutics Holdings business performance
The company's return on equity has surged by 90% YoY but it fell by 18% QoQ
FMTX's ROIC has soared by 71% YoY and by 19% from the previous quarter
FMTX's return on assets is up by 39% year-on-year but it is down by 30% since the previous quarter

Dividends

What is FMTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FMTX.

Financial health

How did Forma Therapeutics Holdings financials performed over time
FMTX's quick ratio has soared by 196% year-on-year but it is down by 3.4% since the previous quarter
FMTX's current ratio has soared by 149% YoY but it is down by 2.7% QoQ
FMTX's debt is 99% smaller than its equity
FMTX's equity is down by 4.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.